These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 22399617)
21. Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies. Avgeris M; Scorilas A Expert Opin Ther Targets; 2016 Jul; 20(7):801-18. PubMed ID: 26941073 [TBL] [Abstract][Full Text] [Related]
22. Synergistic effect of different levels of genomic data for cancer clinical outcome prediction. Kim D; Shin H; Song YS; Kim JH J Biomed Inform; 2012 Dec; 45(6):1191-8. PubMed ID: 22910106 [TBL] [Abstract][Full Text] [Related]
23. Genomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas. Bayani J; Marrano P; Graham C; Zheng Y; Li L; Katsaros D; Lassus H; Butzow R; Squire JA; Diamandis EP Mol Oncol; 2011 Feb; 5(1):48-60. PubMed ID: 20800559 [TBL] [Abstract][Full Text] [Related]
24. Kallikreins as microRNA targets: an in silico and experimental-based analysis. Chow TF; Crow M; Earle T; El-Said H; Diamandis EP; Yousef GM Biol Chem; 2008 Jun; 389(6):731-8. PubMed ID: 18627289 [TBL] [Abstract][Full Text] [Related]
26. The expanded human kallikrein (KLK) gene family: genomic organisation, tissue-specific expression and potential functions. Clements J; Hooper J; Dong Y; Harvey T Biol Chem; 2001 Jan; 382(1):5-14. PubMed ID: 11258672 [TBL] [Abstract][Full Text] [Related]
27. Old genes and new genes: the evolution of the kallikrein locus. Lundwall A Thromb Haemost; 2013 Sep; 110(3):469-75. PubMed ID: 23571662 [TBL] [Abstract][Full Text] [Related]
29. Human tissue kallikrein gene family: applications in cancer. Obiezu CV; Diamandis EP Cancer Lett; 2005 Jun; 224(1):1-22. PubMed ID: 15911097 [TBL] [Abstract][Full Text] [Related]
30. Discovery of novel transcripts of the human tissue kallikrein (KLK1) and kallikrein-related peptidase 2 (KLK2) in human cancer cells, exploiting Next-Generation Sequencing technology. Adamopoulos PG; Kontos CK; Scorilas A Genomics; 2019 Jul; 111(4):642-652. PubMed ID: 29614347 [TBL] [Abstract][Full Text] [Related]
31. Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs). Ramsay AJ; Reid JC; Adams MN; Samaratunga H; Dong Y; Clements JA; Hooper JD Biol Chem; 2008 Jun; 389(6):653-68. PubMed ID: 18627286 [TBL] [Abstract][Full Text] [Related]
32. Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer. Bayani J; Paliouras M; Planque C; Shan SJ; Graham C; Squire JA; Diamandis EP Mol Oncol; 2008 Oct; 2(3):250-60. PubMed ID: 19383346 [TBL] [Abstract][Full Text] [Related]
33. Seminal fluid characterization for male fertility and prostate cancer: kallikrein-related serine proteases and whole proteome approaches. Veveris-Lowe TL; Kruger SJ; Walsh T; Gardiner RA; Clements JA Semin Thromb Hemost; 2007 Feb; 33(1):87-99. PubMed ID: 17253195 [TBL] [Abstract][Full Text] [Related]
34. Kallikrein-related peptidase (KLK) family mRNA variants and protein isoforms in hormone-related cancers: do they have a function? Tan OL; Whitbread AK; Clements JA; Dong Y Biol Chem; 2006 Jun; 387(6):697-705. PubMed ID: 16800730 [TBL] [Abstract][Full Text] [Related]
35. Interdependence of kallikrein-related peptidases in proteolytic networks. Beaufort N; Plaza K; Utzschneider D; Schwarz A; Burkhart JM; Creutzburg S; Debela M; Schmitt M; Ries C; Magdolen V Biol Chem; 2010 May; 391(5):581-7. PubMed ID: 20302517 [TBL] [Abstract][Full Text] [Related]
36. The miRNA-kallikrein interaction: a mosaic of epigenetic regulation in cancer. Di Meo A; Wang C; Cheng Y; Diamandis EP; Yousef GM Biol Chem; 2018 Sep; 399(9):973-982. PubMed ID: 29604203 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of kallikrein-related peptidase 5 expression and its significance for breast cancer patients: association with kallikrein-related peptidase 7 expression. Talieri M; Devetzi M; Scorilas A; Prezas P; Ardavanis A; Apostolaki A; Karameris A Anticancer Res; 2011 Sep; 31(9):3093-100. PubMed ID: 21868565 [TBL] [Abstract][Full Text] [Related]
38. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer. Kim H; Scorilas A; Katsaros D; Yousef GM; Massobrio M; Fracchioli S; Piccinno R; Gordini G; Diamandis EP Br J Cancer; 2001 Mar; 84(5):643-50. PubMed ID: 11237385 [TBL] [Abstract][Full Text] [Related]
39. Association between kallikrein-related peptidases (KLKs) and macroscopic indicators of semen analysis: their relation to sperm motility. Emami N; Scorilas A; Soosaipillai A; Earle T; Mullen B; Diamandis EP Biol Chem; 2009 Sep; 390(9):921-9. PubMed ID: 19558318 [TBL] [Abstract][Full Text] [Related]
40. Kallikrein-related peptidases in cancers of gastrointestinal tract: an inside view of their role and clinical significance. Linardoutsos D; Gazouli M; Machairas A; Bramis I; Zografos GC J BUON; 2014; 19(1):53-9. PubMed ID: 24659643 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]